PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CLOV vs. MA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CLOV and MA is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CLOV vs. MA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and Mastercard Inc (MA). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%SeptemberOctoberNovemberDecember2025February
-61.08%
98.74%
CLOV
MA

Key characteristics

Sharpe Ratio

CLOV:

4.08

MA:

1.37

Sortino Ratio

CLOV:

4.19

MA:

1.94

Omega Ratio

CLOV:

1.50

MA:

1.25

Calmar Ratio

CLOV:

3.52

MA:

1.87

Martin Ratio

CLOV:

22.78

MA:

4.57

Ulcer Index

CLOV:

15.02%

MA:

4.83%

Daily Std Dev

CLOV:

83.81%

MA:

16.16%

Max Drawdown

CLOV:

-97.19%

MA:

-62.67%

Current Drawdown

CLOV:

-82.08%

MA:

0.00%

Fundamentals

Market Cap

CLOV:

$2.07B

MA:

$514.95B

EPS

CLOV:

-$0.19

MA:

$13.86

Total Revenue (TTM)

CLOV:

$1.03B

MA:

$28.17B

Gross Profit (TTM)

CLOV:

$465.18M

MA:

$25.83B

EBITDA (TTM)

CLOV:

-$22.84M

MA:

$16.86B

Returns By Period

In the year-to-date period, CLOV achieves a 26.03% return, which is significantly higher than MA's 9.61% return.


CLOV

YTD

26.03%

1M

-10.38%

6M

50.95%

1Y

358.85%

5Y*

N/A

10Y*

N/A

MA

YTD

9.61%

1M

1.82%

6M

19.57%

1Y

21.60%

5Y*

14.13%

10Y*

20.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLOV vs. MA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9797
Overall Rank
The Sharpe Ratio Rank of CLOV is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9797
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9595
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9696
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9898
Martin Ratio Rank

MA
The Risk-Adjusted Performance Rank of MA is 8383
Overall Rank
The Sharpe Ratio Rank of MA is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of MA is 8080
Sortino Ratio Rank
The Omega Ratio Rank of MA is 7979
Omega Ratio Rank
The Calmar Ratio Rank of MA is 9090
Calmar Ratio Rank
The Martin Ratio Rank of MA is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CLOV vs. MA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Mastercard Inc (MA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CLOV, currently valued at 4.08, compared to the broader market-3.00-2.00-1.000.001.002.003.004.081.37
The chart of Sortino ratio for CLOV, currently valued at 4.19, compared to the broader market-4.00-2.000.002.004.004.191.94
The chart of Omega ratio for CLOV, currently valued at 1.50, compared to the broader market0.501.001.502.001.501.25
The chart of Calmar ratio for CLOV, currently valued at 3.52, compared to the broader market0.001.002.003.004.005.006.003.521.87
The chart of Martin ratio for CLOV, currently valued at 22.77, compared to the broader market-5.000.005.0010.0015.0020.0025.0022.784.57
CLOV
MA

The current CLOV Sharpe Ratio is 4.08, which is higher than the MA Sharpe Ratio of 1.37. The chart below compares the historical Sharpe Ratios of CLOV and MA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
4.08
1.37
CLOV
MA

Dividends

CLOV vs. MA - Dividend Comparison

CLOV has not paid dividends to shareholders, while MA's dividend yield for the trailing twelve months is around 0.48%.


TTM20242023202220212020201920182017201620152014
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MA
Mastercard Inc
0.48%0.50%0.53%0.56%0.49%0.45%0.44%0.53%0.58%0.74%0.66%0.51%

Drawdowns

CLOV vs. MA - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than MA's maximum drawdown of -62.67%. Use the drawdown chart below to compare losses from any high point for CLOV and MA. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-82.08%
0
CLOV
MA

Volatility

CLOV vs. MA - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 13.00% compared to Mastercard Inc (MA) at 5.19%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than MA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
13.00%
5.19%
CLOV
MA

Financials

CLOV vs. MA - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Mastercard Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab